DNA from ancient Europeans reveals surprising multiple sclerosis origins January 10, 2024 By Will Dunham (Reuters) – DNA obtained from the bones
U.S. FDA approves TG Therapeutics’ multiple sclerosis drug; shares surge December 28, 2022 By Sriparna Roy and Khushi Mandowara (Reuters) – TG Therapeutics